Data / Form D filings / DIADEXUS INC
DIADEXUS INC: Form D filing
DIADEXUS INC, a biotechnology company in South San Francisco, CA, filed a Form D with the SEC in 2010. The latest, on June 8, 2010, reports $4.5 million sold of a $7.5 million offering to 11 investors.
Find out what DIADEXUS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 343 Oyster Point Boulevard, South San Francisco, CA, 94080
- Phone
- (650) 246-6400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1114348
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2010 | New notice | $7,500,000 | $4,500,000 | $3,000,000 | 11 | May 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles W. Patrick | Director | |
| Robert L. Wolfert, Ph.D. | Executive Officer | |
| Michael C Goller | Director | |
| David J. Foster | Executive Officer | |
| Louis C Bock | Director | |
| Bernard M. Alfano | Executive Officer | |
| Kelvin C Neu, MD | Director | |
| Patrick Plewman | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Jun 7, 2010 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DIADEXUS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.